HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.

Abstract
Coronary CT angiography (CCTA) is used in patients with low-intermediate chest pain presenting to the emergency department for its reliability in excluding acute coronary syndrome (ACS). However, its influence on medication modification in this setting is unclear. We sought to determine whether knowledge of CCTA-based coronary artery disease (CAD) was associated with change in statin and aspirin prescription. We used the CCTA arm of the Rule Out Myocardial Infarction using Computed Angiographic Tomography II multicenter, randomized control trial (R-II) and comparison cohort from the observational Rule Out Myocardial Infarction using Computed Angiographic Tomography I cohort (R-I). In R-II, subjects were randomly assigned to CCTA to guide decision making, whereas in R-I patients underwent CCTA with results blinded to caregivers and managed according to standard care. Our final cohort consisted of 277 subjects from R-I and 370 from R-II. ACS rate was similar (6.9% vs 6.2% respectively, p = 0.75). For subjects with CCTA-detected obstructive CAD without ACS, initiation of statin was significantly greater after disclosure of CCTA results (0% in R-I vs 20% in R-II, p = 0.009). Conversely, for subjects without CCTA-detected CAD, aspirin prescription was lower with disclosure of CCTA results (16% in R-I vs 4.8% in R-II, p = 0.001). However, only 68% of subjects in R-II with obstructive CAD were discharged on statin and 65% on aspirin. In conclusion, physician knowledge of CCTA results leads to improved alignment of aspirin and statin with the presence and severity of CAD although still many patients with CCTA-detected CAD are not discharged on aspirin or statin. Our findings suggest opportunity for practice improvement when CCTA is performed in the emergency department.
AuthorsAmit Pursnani, Csilla Celeng, Christopher L Schlett, Thomas Mayrhofer, Pearl Zakroysky, Hang Lee, Maros Ferencik, Jerome L Fleg, Fabian Bamberg, Stephen D Wiviott, Quynh A Truong, James E Udelson, John T Nagurney, Udo Hoffmann
JournalThe American journal of cardiology (Am J Cardiol) Vol. 117 Issue 3 Pg. 319-24 (Feb 01 2016) ISSN: 1879-1913 [Electronic] United States
PMID26762723 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Aspirin
Topics
  • Acute Coronary Syndrome (complications, diagnostic imaging, prevention & control)
  • Adult
  • Aged
  • Aspirin (administration & dosage)
  • Chest Pain (diagnostic imaging, etiology)
  • Coronary Angiography (methods)
  • Decision Making
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Drug Prescriptions (statistics & numerical data)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (administration & dosage)
  • Male
  • Middle Aged
  • Multidetector Computed Tomography (methods)
  • Platelet Aggregation Inhibitors (administration & dosage)
  • Predictive Value of Tests
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: